Why the study?
Does intravenous immunoglobulin arrest progression in patients with multiple sclerosis?
Does intravenous immunoglobulin arrest progression in patients with multiple sclerosis?
Intravenous immunoglobulin did not show clinical or MRI benefit in arresting the progression of multiple sclerosis in a small open-label study.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Francis et al. (1997) studied multiple sclerosis (n=9). intravenous immunoglobulin was evaluated on clinical progression, MRI T2-weighted lesions, and CSF analyses.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: